menu
    • menu

    Company profile for Nkarta Therapeutics

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies. While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited to a few hematologic malignancies and the side effects can be severe. Natural Kil...
    Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies. While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited to a few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nkarta TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6000 Shoreline Court, Suite 102 South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nkartatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nkarta-therapeutics-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nkarta Secures FDA Approval For Outpatient NKX019 Dosing
    Nkarta Secures FDA Approval For Outpatient NKX019 Dosing

    15 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7181729

    FIRSTWORD PHARMA
    15 Apr 2026
    Share Share
    Nkarta To Participate In Needham Virtual Healthcare Conference
    Nkarta To Participate In Needham Virtual Healthcare Conference

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3270795/0/en/Nkarta-to-Participate-in-Needham-Virtual-Healthcare-Conference.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Nkarta Unveils 2025 Financials And Corporate Achievements
    Nkarta Unveils 2025 Financials And Corporate Achievements

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262553/0/en/Nkarta-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Corporate-Highlights.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Nkarta To Participate In March Investor Conferences
    Nkarta To Participate In March Investor Conferences

    27 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/27/3246476/0/en/Nkarta-to-Participate-in-March-Investor-Conferences.html

    GLOBENEWSWIRE
    27 Feb 2026
    Share Share
    Why Nkarta's CEO Wore Head-To-Toe Pink At Jpm—And Why It Matters
    Why Nkarta's CEO Wore Head-To-Toe Pink At Jpm—And Why It Matters

    20 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/nkartas-ceo-wore-head-toe-pink-jpm-heres-why-it-matters-more-ever

    FIERCE BIOTECH
    20 Jan 2026
    Share Share
    Nkarta To Participate In Evercore Healthcare Conference
    Nkarta To Participate In Evercore Healthcare Conference

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197769/0/en/Nkarta-to-Participate-in-Evercore-Healthcare-Conference.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search